Dentistry

Why clenching your teeth as long you can? Solve the problem with a smile

Periodontitis is an inflammation of the periodontium and one of the most common dental diseases. Often traditional medication only reaches the acutely inflamed part of the wound – the process is shifted from an acute to a chronic condition. If left untreated, in the long run periodontitis can lead to tooth loss and it increases the risk of cardiovascular disease, high blood pressure, diabetes and others.

That is why it is crucial to develop an appropriate treatment strategy which could quickly stop the inflammation, repair the damaged tissue and improve the quality of life of the patient.

Thanks to Sanakin-Technology physicians can quickly cope with Periodontitis and jawbone diseases achieving high tolerability and effectiveness and avoiding artificial additives all together. The focus of the 100% autologous serum is on the production of positive cytokines which decisively intervene in the inflammation, regulate it and subsequently trigger regenerative processes.
Sanakin-Technology offers you a unique opportunity to treat inflammation and tissue damage in a purely biological and completely endogenous way. Don’t hesitate to apply this advanced technology in your Dental practice as it is highly tolerable and allows for basically unlimited therapy duration.

1. Blood Collection

2. Incubation

3. Centrifugation

4. Application

To find the optimal solution runs in our blood

The Sanakin-Technology is an innovative development in which a completely autologous cytokine-rich serum (ACRS) is obtained from the patient’s own blood to ensure the effectiveness and success of the treatment.

This serum contains high concentration of cytokines – signaling proteins that control inflammation and tissue regeneration processes. When multiplied, these body’s own messenger substances can act exactly where they are needed.

Nice to meet your needs

Who are we?

We are Sanakin BioScience – a team of hearty professionals in the advanced technology of autologous cytokine-rich serum (ACRS) creation that supports body’s own regenerative powers and acts exactly where needed.

What do we aim for?

For the autologous treatment to become a top-of-mind opportunity for physicians and patients all over the world, so they could confidently say:
“There are 3 options: surgery, medications or Sanakin-Technology“. Because together we can make life worth living and enjoyable in a purely biological and completely endogenous way.

Our body believes in us

And we believe in...

Naturality

The body has the natural ability to deal with inflammation. That is why our focus is on the production of a 100% autologous serum avoiding any artificial additives.

Personality

We have discovered the key to successful treatment in each one of us. Our technology is based on the patient’s own blood and always offers an individual approach.

Multifunctionality

We invest a lot of time and effort in scientific studies that confirm the effectiveness of the treatment and help us expand the fields of application.

Exellence

We are constantly looking for new opportunities for improvement to obtain maximum results.

Collaboration

We are open to establishing long-term and trusted relationships with partners and doctors who specialize in regenerative medicine.

Working progress

2010 ........................

The German company was established to start working with the immune proteins in orthopaedics and marks the beginning of Sanakin-Technology

2013 ........................

Expansion to other fields of application and markets

2021 ........................

Branches in Switzerland and Bulgaria were opened

2023 ........................

Partnerships with distributors from over 50 countries on 4 continents

Your message